Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

Thursday’s trading has closed, but OMER is being traded in the after-hours session. After-Hours quote »
10.53
Delayed Data
As of 4:00pm ET
 +0.02 / +0.19%
Today’s Change
8.90
Today|||52-Week Range
30.23
-33.06%
Year-to-Date
No recent news for Omeros Corp.

Today’s Trading

Previous close10.51
Today’s open10.40
Day’s range9.98 - 10.68
Volume247,810
Average volume (3 months)402,850
Market cap$399.1M
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-59.71%
Earnings growth (this year)+9.37%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)-66.31%
P/E ratioNM
Price/Sales1,527.91
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.01-1.46%
ACRSAclaris Therapeutics...-0.22-1.09%
SGYPSynergy Pharmaceutic...+0.02+0.58%
OTICOtonomy Inc+0.76+5.76%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$539.0K
Annual profit (last year)-$73.7M
Net profit margin-13,668.46%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
Senior Director-
Finance
David R. Toll
Corporate headquarters
Seattle, Washington

Forecasts

Partner Offers